Urological cancer, Malmö
341 – 350 of 499
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
(
- Contribution to journal › Scientific review
-
Mark
Tumour markers in prostate cancer III: Biomarkers in urine
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
2011) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 24. p.708-719(
- Contribution to journal › Article
-
Mark
AUTOMATED IMAGE ANALYSIS CONFIRMS THE PREDICTIVE SIGNIFICANCE OF MSMB IN PROSTATE CANCER
(
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
-
Mark
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
(
- Contribution to journal › Article
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
Translational perspectives on MSMB and CRISP3 expression and regulation in prostate cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.237-238(
- Contribution to journal › Published meeting abstract